B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MAN2B1

MOLECULAR TARGET

mannosidase alpha class 2B member 1

UniProt: O00754NCBI Gene: 41251 compounds

MAN2B1 (mannosidase alpha class 2B member 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MAN2B1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Swainsonine1.393

About MAN2B1 as a Drug Target

MAN2B1 (mannosidase alpha class 2B member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented MAN2B1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MAN2B1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.